{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T17:50:56Z","timestamp":1790185856585,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T00:00:00Z","timestamp":1557792000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T00:00:00Z","timestamp":1557792000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"the Research Committee for Ataxic Disease"},{"name":"the ICT Infrastructure Establishment and Implementation of Artificial Intelligence for Clinical and Medical Research"},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP17ek0109110"],"award-info":[{"award-number":["JP17ek0109110"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP16ek0109048"],"award-info":[{"award-number":["JP16ek0109048"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP18ek0109368"],"award-info":[{"award-number":["JP18ek0109368"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Brain"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13041-019-0471-2","type":"journal-article","created":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T15:04:43Z","timestamp":1557846283000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":66,"title":["Identification of plasma microRNA expression changes in multiple system atrophy and Parkinson\u2019s disease"],"prefix":"10.1186","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0353-8215","authenticated-orcid":false,"given":"Hisashi","family":"Uwatoko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Hama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikuko Takahashi","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Shirai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Matsushima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiro","family":"Yabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Utsumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidenao","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,14]]},"reference":[{"issue":"1","key":"471_CR1","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/S0022-510X(98)00304-9","volume":"163","author":"S Gilman","year":"1999","unstructured":"Gilman S, Low PA, Quinn N, Albanese A, Ben-Shlomo Y, Fowler CJ, et al. Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci. 1999;163(1):94\u20138.","journal-title":"J Neurol Sci"},{"issue":"6","key":"471_CR2","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1111\/j.1365-2990.2007.00907.x","volume":"33","author":"JQ Trojanowski","year":"2007","unstructured":"Trojanowski JQ, Revesz T. Neuropathology working group on MSA. Proposed neuropathological criteria for the post mortem diagnosis of multiple system atrophy. Neuropathol Appl Neurobiol. 2007;33(6):615\u201320.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"471_CR3","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1093\/brain\/117.4.835","volume":"117","author":"GK Wenning","year":"1994","unstructured":"Wenning GK, Ben Shlomo Y, Magalhaes M, Daniel SE, Quinn NP. Clinical features and natural history of multiple system atrophy. An analysis of 100 cases. Brain. 1994;117 (Pt 4:835\u201345.","journal-title":"Brain."},{"issue":"2","key":"471_CR4","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1002\/mds.870120203","volume":"12","author":"GK Wenning","year":"1997","unstructured":"Wenning GK, Tison F, Ben Shlomo Y, Daniel SE, Quinn NP. Multiple system atrophy: a review of 203 pathologically proven cases. Mov Disord. 1997;12(2):133\u201347.","journal-title":"Mov Disord"},{"issue":"12","key":"471_CR5","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1016\/S1474-4422(09)70238-8","volume":"8","author":"DW Dickson","year":"2009","unstructured":"Dickson DW, Braak H, Duda JE, Duyckaerts C, Gasser T, Halliday GM, et al. Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria. Lancet Neurol. 2009;8(12):1150\u20137.","journal-title":"Lancet Neurol"},{"issue":"1","key":"471_CR6","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/nrneurol.2012.242","volume":"9","author":"M Goedert","year":"2013","unstructured":"Goedert M, Spillantini MG, Del Tredici K, Braak H. 100 years of Lewy pathology. Nat Rev Neurol. 2013;9(1):13\u201324.","journal-title":"Nat Rev Neurol"},{"issue":"2","key":"471_CR7","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","volume":"116","author":"DP Bartel","year":"2004","unstructured":"Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116(2):281\u201397.","journal-title":"Cell."},{"issue":"3","key":"471_CR8","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/nrd.2016.246","volume":"16","author":"R Rupaimoole","year":"2017","unstructured":"Rupaimoole R, Slack FJ. MicroRNA therapeutics: towards a new era for the management of cancer and other diseases. Nat Rev Drug Discov. 2017;16(3):203\u201321.","journal-title":"Nat Rev Drug Discov"},{"issue":"4","key":"471_CR9","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/nrn3879","volume":"16","author":"O Issler","year":"2015","unstructured":"Issler O, Chen A. Determining the role of microRNAs in psychiatric disorders. Nat Rev Neurosci. 2015;16(4):201\u201312.","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"471_CR10","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/jcp.25056","volume":"231","author":"J Wang","year":"2016","unstructured":"Wang J, Chen J, Sen S. MicroRNA as biomarkers and diagnostics. J Cell Physiol. 2016;231(1):25\u201330.","journal-title":"J Cell Physiol"},{"issue":"5","key":"471_CR11","doi-asserted-by":"publisher","first-page":"4015","DOI":"10.3892\/mmr.2016.5759","volume":"14","author":"FC da Silva","year":"2016","unstructured":"da Silva FC, Iop RD, Vietta GG, Kair DA, Gutierres Filho PJ, de Alvarenga JG, et al. microRNAs involved in Parkinson's disease: a systematic review. Mol Med Rep. 2016;14(5):4015\u201322.","journal-title":"Mol Med Rep"},{"key":"471_CR12","doi-asserted-by":"crossref","unstructured":"Takahashi I, Hama Y, Matsushima M, Hirotani M, Kano T, Hohzen H, et al. Identification of plasma microRNAs as a biomarker of sporadic amyotrophic lateral sclerosis. Mol Brain. 2015;8.","DOI":"10.1186\/s13041-015-0161-7"},{"issue":"3","key":"471_CR13","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1177\/1352458516651141","volume":"23","author":"J Vistbakka","year":"2017","unstructured":"Vistbakka J, Elovaara I, Lehtimaki T, Hagman S. Circulating microRNAs as biomarkers in progressive multiple sclerosis. Mult Scler. 2017;23(3):403\u201312.","journal-title":"Mult Scler"},{"key":"471_CR14","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.jns.2015.12.005","volume":"360","author":"V Van Giau","year":"2016","unstructured":"Van Giau V, An SS. Emergence of exosomal miRNAs as a diagnostic biomarker for Alzheimer's disease. J Neurol Sci. 2016;360:141\u201352.","journal-title":"J Neurol Sci"},{"issue":"9","key":"471_CR15","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1212\/01.wnl.0000324625.00404.15","volume":"71","author":"S Gilman","year":"2008","unstructured":"Gilman S, Wenning GK, Low PA, Brooks DJ, Mathias CJ, Trojanowski JQ, et al. Second consensus statement on the diagnosis of multiple system atrophy. Neurology. 2008;71(9):670\u20136.","journal-title":"Neurology."},{"issue":"11","key":"471_CR16","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1212\/01.wnl.0000219042.60538.92","volume":"66","author":"T Schmitz-Hubsch","year":"2006","unstructured":"Schmitz-Hubsch T, du Montcel ST, Baliko L, Berciano J, Boesch S, Depondt C, et al. Scale for the assessment and rating of ataxia: development of a new clinical scale. Neurology. 2006;66(11):1717\u201320.","journal-title":"Neurology."},{"key":"471_CR17","first-page":"61","volume":"14","author":"FI Mahoney","year":"1965","unstructured":"Mahoney FI, Barthel DW. Functional evaluation: the Barthel index. Md State Med J. 1965;14:61\u20135.","journal-title":"Md State Med J"},{"issue":"12","key":"471_CR18","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1002\/mds.20255","volume":"19","author":"GK Wenning","year":"2004","unstructured":"Wenning GK, Tison F, Seppi K, Sampaio C, Diem A, Yekhlef F, et al. Development and validation of the unified multiple system atrophy rating scale (UMSARS). Mov Disord. 2004;19(12):1391\u2013402.","journal-title":"Mov Disord"},{"key":"471_CR19","volume-title":"Recent developments in Parkinson's disease. II","author":"SER Fahn","year":"1987","unstructured":"Fahn SER. Members of the UPDRS Development Committee. . Unified Parkinson\u2019s disease rating scale. In: Fahn DMC, Calne D, Goldstein M, editors. Recent developments in Parkinson's disease. II. Florham Park: Macmillan Healthcare Information; 1987."},{"issue":"23","key":"471_CR20","doi-asserted-by":"publisher","first-page":"E5334","DOI":"10.1073\/pnas.1714397115","volume":"115","author":"KEA Max","year":"2018","unstructured":"Max KEA, Bertram K, Akat KM, Bogardus KA, Li J, Morozov P, et al. Human plasma and serum extracellular small RNA reference profiles and their clinical utility. Proc Natl Acad Sci U S A. 2018;115(23):E5334\u2013E43.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"471_CR21","doi-asserted-by":"publisher","first-page":"e41561","DOI":"10.1371\/journal.pone.0041561","volume":"7","author":"K Wang","year":"2012","unstructured":"Wang K, Yuan Y, Cho JH, McClarty S, Baxter D, Galas DJ. Comparing the MicroRNA Spectrum between serum and plasma. PLoS One. 2012;7(7):e41561.","journal-title":"PLoS One"},{"issue":"22","key":"471_CR22","doi-asserted-by":"publisher","first-page":"11673","DOI":"10.1093\/nar\/gks901","volume":"40","author":"CE Vejnar","year":"2012","unstructured":"Vejnar CE, Zdobnov EM. MiRmap: comprehensive prediction of microRNA target repression strength. Nucleic Acids Res. 2012;40(22):11673\u201383.","journal-title":"Nucleic Acids Res"},{"issue":"10","key":"471_CR23","first-page":"1319","volume":"72","author":"LM Margolis","year":"2017","unstructured":"Margolis LM, Lessard SJ, Ezzyat Y, Fielding RA, Rivas DA. Circulating MicroRNA are predictive of aging and acute adaptive response to resistance exercise in men. J Gerontol A Biol Sci Med Sci. 2017;72(10):1319\u201326.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"10","key":"471_CR24","doi-asserted-by":"publisher","first-page":"725","DOI":"10.18632\/aging.100603","volume":"5","author":"N Noren Hooten","year":"2013","unstructured":"Noren Hooten N, Fitzpatrick M, Wood WH 3rd, De S, Ejiogu N, Zhang Y, et al. Age-related changes in microRNA levels in serum. Aging (Albany NY). 2013;5(10):725\u201340.","journal-title":"Aging (Albany NY)"},{"issue":"3","key":"471_CR25","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1111\/ane.12616","volume":"135","author":"M Ferreira","year":"2017","unstructured":"Ferreira M, Massano J. An updated review of Parkinson's disease genetics and clinicopathological correlations. Acta Neurol Scand. 2017;135(3):273\u201384.","journal-title":"Acta Neurol Scand"},{"issue":"5","key":"471_CR26","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1002\/ana.21685","volume":"65","author":"SW Scholz","year":"2009","unstructured":"Scholz SW, Houlden H, Schulte C, Sharma M, Li A, Berg D, et al. SNCA variants are associated with increased risk for multiple system atrophy. Ann Neurol. 2009;65(5):610\u20134.","journal-title":"Ann Neurol"},{"issue":"3","key":"471_CR27","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1056\/NEJMoa1212115","volume":"369","author":"Multiple-System Atrophy Research C","year":"2013","unstructured":"Multiple-System Atrophy Research C. Mutations in COQ2 in familial and sporadic multiple-system atrophy. N Engl J Med. 2013;369(3):233\u201344.","journal-title":"N Engl J Med"},{"issue":"15","key":"471_CR28","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1212\/WNL.0000000000003221","volume":"87","author":"A Sailer","year":"2016","unstructured":"Sailer A, Scholz SW, Nalls MA, Schulte C, Federoff M, Price TR, et al. A genome-wide association study in multiple system atrophy. Neurology. 2016;87(15):1591\u20138.","journal-title":"Neurology."},{"issue":"1","key":"471_CR29","doi-asserted-by":"publisher","first-page":"293","DOI":"10.18632\/oncotarget.6344","volume":"7","author":"X Tan","year":"2016","unstructured":"Tan X, Fu Y, Chen L, Lee W, Lai Y, Rezaei K, et al. miR-671-5p inhibits epithelial-to-mesenchymal transition by downregulating FOXM1 expression in breast cancer. Oncotarget. 2016;7(1):293\u2013307.","journal-title":"Oncotarget."},{"issue":"4","key":"471_CR30","doi-asserted-by":"publisher","first-page":"4746","DOI":"10.18632\/oncotarget.6621","volume":"7","author":"D Barbagallo","year":"2016","unstructured":"Barbagallo D, Condorelli A, Ragusa M, Salito L, Sammito M, Banelli B, et al. Dysregulated miR-671-5p \/ CDR1-AS \/ CDR1 \/ VSNL1 axis is involved in glioblastoma multiforme. Oncotarget. 2016;7(4):4746\u201359.","journal-title":"Oncotarget."},{"issue":"3","key":"471_CR31","first-page":"2420","volume":"16","author":"X Zhang","year":"2018","unstructured":"Zhang X, Xin G, Sun D. Serum exosomal miR-328, miR-575, miR-134 and miR-671-5p as potential biomarkers for the diagnosis of Kawasaki disease and the prediction of therapeutic outcomes of intravenous immunoglobulin therapy. Exp Ther Med. 2018;16(3):2420\u201332.","journal-title":"Exp Ther Med"},{"issue":"4","key":"471_CR32","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s10014-017-0295-7","volume":"34","author":"PB Malgulwar","year":"2017","unstructured":"Malgulwar PB, Pathak P, Singh M, Kale SS, Suri V, Sarkar C, et al. Downregulation of SMARCB1\/INI1 expression in pediatric chordomas correlates with upregulation of miR-671-5p and miR-193a-5p expressions. Brain Tumor Pathol. 2017;34(4):155\u20139.","journal-title":"Brain Tumor Pathol"},{"key":"471_CR33","doi-asserted-by":"publisher","first-page":"3983","DOI":"10.1113\/jphysiol.2011.213363","volume":"589","author":"AL Baggish","year":"2011","unstructured":"Baggish AL, Hale A, Weiner RB, Lewis GD, Systrom D, Wang F, et al. Dynamic regulation of circulating microRNA during acute exhaustive exercise and sustained aerobic exercise training. J Physiol. 2011;589(Pt 16:3983\u201394.","journal-title":"J Physiol"},{"issue":"1","key":"471_CR34","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1158\/1055-9965.EPI-16-0969","volume":"27","author":"S Dufresne","year":"2018","unstructured":"Dufresne S, Rebillard A, Muti P, Friedenreich CM, Brenner DR. A review of physical activity and circulating miRNA expression: implications in cancer risk and progression. Cancer Epidemiol Biomark Prev. 2018;27(1):11\u201324.","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"11","key":"471_CR35","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1002\/mds.23841","volume":"26","author":"J Marusiak","year":"2011","unstructured":"Marusiak J, Jaskolska A, Budrewicz S, Koszewicz M, Jaskolski A. Increased muscle belly and tendon stiffness in patients with Parkinson's disease, as measured by myotonometry. Mov Disord. 2011;26(11):2119\u201322.","journal-title":"Mov Disord"},{"issue":"12","key":"471_CR36","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1007\/s00702-005-0381-6","volume":"112","author":"S Gilman","year":"2005","unstructured":"Gilman S, May SJ, Shults CW, Tanner CM, Kukull W, Lee VM, et al. The North American multiple system atrophy study group. J Neural Transm (Vienna). 2005;112(12):1687\u201394.","journal-title":"J Neural Transm (Vienna)"},{"issue":"15","key":"471_CR37","doi-asserted-by":"publisher","first-page":"2604","DOI":"10.1002\/mds.23192","volume":"25","author":"M Kollensperger","year":"2010","unstructured":"Kollensperger M, Geser F, Ndayisaba JP, Boesch S, Seppi K, Ostergaard K, et al. Presentation, diagnosis, and management of multiple system atrophy in Europe: final analysis of the European multiple system atrophy registry. Mov Disord. 2010;25(15):2604\u201312.","journal-title":"Mov Disord"},{"issue":"5","key":"471_CR38","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1093\/brain\/awf117","volume":"125","author":"H Watanabe","year":"2002","unstructured":"Watanabe H, Saito Y, Terao S, Ando T, Kachi T, Mukai E, et al. Progression and prognosis in multiple system atrophy. Brain. 2002;125(5):1070\u201383.","journal-title":"Brain."},{"issue":"6","key":"471_CR39","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1007\/s12311-015-0668-6","volume":"14","author":"K Sakushima","year":"2015","unstructured":"Sakushima K, Nishimoto N, Nojima M, Matsushima M, Yabe I, Sato N, et al. Epidemiology of multiple system atrophy in Hokkaido, the Northernmost Island of Japan. Cerebellum. 2015;14(6):682\u20137.","journal-title":"Cerebellum."},{"issue":"2","key":"471_CR40","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.jns.2006.05.064","volume":"249","author":"I Yabe","year":"2006","unstructured":"Yabe I, Soma H, Takei A, Fujiki N, Yanagihara T, Sasaki H. MSA-C is the predominant clinical phenotype of MSA in Japan: analysis of 142 patients with probable MSA. J Neurol Sci. 2006;249(2):115\u201321.","journal-title":"J Neurol Sci"},{"issue":"12","key":"471_CR41","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1097\/00005072-199812000-00001","volume":"57","author":"PL Lantos","year":"1998","unstructured":"Lantos PL. The definition of multiple system atrophy: a review of recent developments. J Neuropath Exp Neur. 1998;57(12):1099\u2013111.","journal-title":"J Neuropath Exp Neur"},{"issue":"9","key":"471_CR42","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1136\/jnnp.57.9.1047","volume":"57","author":"JB Schulz","year":"1994","unstructured":"Schulz JB, Klockgether T, Petersen D, Jauch M, Muller-Schauenburg W, Spieker S, et al. Multiple system atrophy: natural history, MRI morphology, and dopamine receptor imaging with 123IBZM-SPECT. J Neurol Neurosurg Psychiatry. 1994;57(9):1047\u201356.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"471_CR43","doi-asserted-by":"publisher","first-page":"156","DOI":"10.3389\/fncel.2014.00156","volume":"8","author":"A Vallelunga","year":"2014","unstructured":"Vallelunga A, Ragusa M, Di Mauro S, Iannitti T, Pilleri M, Biundo R, et al. Identification of circulating microRNAs for the differential diagnosis of Parkinson's disease and multiple system atrophy. Front Cell Neurosci. 2014;8:156.","journal-title":"Front Cell Neurosci"},{"issue":"8","key":"471_CR44","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1002\/jnr.23377","volume":"92","author":"T Botta-Orfila","year":"2014","unstructured":"Botta-Orfila T, Morato X, Compta Y, Lozano JJ, Falgas N, Valldeoriola F, et al. Identification of blood serum micro-RNAs associated with idiopathic and LRRK2 Parkinson's disease. J Neurosci Res. 2014;92(8):1071\u20137.","journal-title":"J Neurosci Res"},{"issue":"10","key":"471_CR45","doi-asserted-by":"publisher","first-page":"7736","DOI":"10.1007\/s12035-016-0253-0","volume":"54","author":"TM Marques","year":"2017","unstructured":"Marques TM, Kuiperij HB, Bruinsma IB, van Rumund A, Aerts MB, Esselink RAJ, et al. MicroRNAs in cerebrospinal fluid as potential biomarkers for Parkinson\u2019s disease and multiple system atrophy. Mol Neurobiol. 2017;54(10):7736\u201345.","journal-title":"Mol Neurobiol"}],"container-title":["Molecular Brain"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13041-019-0471-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13041-019-0471-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13041-019-0471-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T09:47:37Z","timestamp":1589536057000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecularbrain.biomedcentral.com\/articles\/10.1186\/s13041-019-0471-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,14]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["471"],"URL":"https:\/\/doi.org\/10.1186\/s13041-019-0471-2","relation":{},"ISSN":["1756-6606"],"issn-type":[{"value":"1756-6606","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,14]]},"assertion":[{"value":"30 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Medical Ethics Committee of the Hokkaido University Graduate School of Medicine, and written informed consents were obtained from all participants.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"49"}}